Standard Family Office LLC Dexcom Inc Transaction History

Standard Family Office LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $5,191 - $6,404	68 New	68 $5,000
Q3 2021 Nov 15, 2021	SELL	$106.71 - $143.18 $243,085 - $326,164	-2,278 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$84.79 - $104.74 $24,843 - $30,688	293 Added 14.76%	2,278 $819,000
Q4 2020 Feb 16, 2021	BUY	$78.0 - $104.5 $154,830 - $207,432	1,985 New	1,985 $734,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Standard Family Office LLC, based on Form 13F filings with the SEC.

Stay updated on Standard Family Office LLC with notifications on news.